A detailed history of Ghost Tree Capital, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 265,000 shares of RGNX stock, worth $2.02 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
265,000
Previous 170,000 55.88%
Holding current value
$2.02 Million
Previous $1.99 Million 39.79%
% of portfolio
1.04%
Previous 0.81%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.49 - $14.39 $996,550 - $1.37 Million
95,000 Added 55.88%
265,000 $2.78 Million
Q2 2024

Aug 14, 2024

BUY
$11.51 - $21.53 $575,500 - $1.08 Million
50,000 Added 41.67%
170,000 $1.99 Million
Q1 2024

May 15, 2024

BUY
$12.17 - $24.61 $1.46 Million - $2.95 Million
120,000 New
120,000 $2.53 Million
Q4 2020

Feb 16, 2021

SELL
$26.52 - $49.35 $1.99 Million - $3.7 Million
-75,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$27.01 - $40.26 $2.03 Million - $3.02 Million
75,000 New
75,000 $2.06 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.